ACBD3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.101800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.752180E-01
Normal-vs-Stage2
1.972170E-01
Normal-vs-Stage3
6.548800E-01
Normal-vs-Stage4
3.714400E-02
Stage1-vs-Stage2
8.043800E-01
Stage1-vs-Stage3
2.667400E-01
Stage1-vs-Stage4
1.402450E-01
Stage2-vs-Stage3
3.088800E-01
Stage2-vs-Stage4
3.856200E-02
Stage3-vs-Stage4
3.717800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.376200E-01
Normal-vs-AfricanAmerican
5.389800E-02
Normal-vs-Asian
2.172200E-01
Caucasian-vs-AfricanAmerican
1.818190E-01
Caucasian-vs-Asian
6.707200E-01
AfricanAmerican-vs-Asian
3.994600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.165200E-01
Normal-vs-Female
2.018200E-01
Male-vs-Female
4.961400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.207400E-01
Normal-vs-Age(41-60Yrs)
1.435820E-01
Normal-vs-Age(61-80Yrs)
2.455800E-01
Normal-vs-Age(81-100Yrs)
3.217600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.583800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.837200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.123000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.762500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.693200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.485200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.267600E-01
Normal-vs-Daily Drinker
6.026000E-01
Normal-vs-Weekly Drinker
2.995200E-01
Normal-vs-Occasional Drinker
1.430980E-01
Normal-vs-Social Drinker
2.666600E-01
Non Drinker-vs-Daily Drinker
1.960960E-01
Non Drinker-vs-Weekly Drinker
8.486400E-01
Non Drinker-vs-Occasional Drinker
9.084100E-02
Non Drinker-vs-Social Drinker
6.742800E-01
Daily Drinker-vs-Weekly Drinker
2.567400E-01
Daily Drinker-vs-Occasional Drinker
1.244260E-02
Daily Drinker-vs-Social Drinker
1.815200E-01
Weekly Drinker-vs-Occasional Drinker
2.020000E-01
Weekly Drinker-vs-Social Drinker
8.641000E-01
Occasional Drinker-vs-Social Drinker
2.519200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.842100E-02
Normal-vs-Grade 2
7.404200E-03
Normal-vs-Grade 3
7.701600E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.961900E-02
Grade 1-vs-Grade 3
7.703800E-02
Grade 1-vs-Grade 4
6.842100E-02
Grade 2-vs-Grade 3
8.817000E-01
Grade 2-vs-Grade 4
7.404200E-03
Grade 3-vs-Grade 4
7.701600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.149600E-01
Normal-vs-NonDiabetic
2.195400E-01
Diabetic-vs-NonDiabetic
2.964000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.866600E-01
Normal-vs-NoPancreatitis
2.431200E-01
Pancreatitis-vs-NoPancreatitis
5.586400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.732580E-01
Normal-vs-N1
2.185800E-01
N0-vs-N1
7.649600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.138370E-01
Normal-vs-TP53-NonMutant
2.058200E-01
TP53-Mutant-vs-TP53-NonMutant
4.462000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
